General Information of Drug (ID: DM3A701)

Drug Name
IDP-122 Drug Info
Indication
Disease Entry ICD 11 Status REF
Exanthem Approved [1]
Granuloma annulare Approved [1]
Primary cutaneous T-cell lymphoma Approved [1]
Plaque psoriasis EA90.0 Phase 3 [2]
Cross-matching ID
PubChem CID
5311167
TTD Drug ID
DM3A701

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cortisone Acetate DMG8K57 Acne vulgaris ED80 Approved [3]
Beclomethasone DMZPHIK Allergic rhinitis CA08.0 Approved [3]
Auranofin DMWE2N4 Inflammatory arthritis FA2Z Approved [3]
Loteprednol Etabonate DM8QTJI Eye inflammation 9A02 Approved [3]
Desonide DMTP2NJ Allergic rhinitis CA08.0 Approved [3]
Fluocinonide DM65KL8 Exanthem Approved [3]
Medrysone DMJ90O5 Corneal abrasion NA06.4 Approved [3]
Halcinonide DMGLAX1 Exanthem Approved [3]
Amcinonide DMM1JL9 Exanthem Approved [3]
Prednicarbate DMBUNVW Exanthem Approved [3]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Steroid hormone receptor ERR (ESRR) TTP3UTW ERR1_HUMAN; ERR2_HUMAN; ERR3_HUMAN Agonist [2]

References

1 A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.